None listed
Conditions
Brief summary
The participant population is Adult Emergency Department (ED) patients who have a requirement for respiratory support. The purpose of this study is to examine the nature of the respiratory support delivered in the ED. There shall be a specific focus on Nasal High Flow (NHF) therapy delivered to adults in the ED. This study shall explore the influence that this support has upon patient outcomes. The overarching research questions are: • What is the nature of the NHF delivered to adults in the ED setting? • What influence does the delivery of NHF have upon adult ED patient outcomes? The five specific research sub-questions are: • Who receives NHF in the ED? • How is NHF delivered in the ED? • Which patients receiving NHF require escalation of therapy in the ED? • What are the effects seen with NHF therapy on physiological and patient-centred outcomes?
Interventions
Nasal High Flow therapy delivered via a nasal interface : Heated and humidified gas flow rates from 5- 60 L/min FiO2 21- 100% Temperature 32-37 C Patients will receive this therapy regardless of whether they are enrolled in the study or not, and at the discretion of their clinicians Only data from clinical records shall be collected ie there is no additional involvement for patients The duration of patient involvement is 30 days post ED admission The data will be collected in 2 , 12 hour cross sections of time separated by 4 weeks The data sources are from within 4 EDs within 4 District Area Health Boards (DHBs) in NZ
Sponsors
Eligibility
Inclusion criteria
Adult Emergency Department Patient Requirement for any form or combination of respiratory support (via COT, NIV, NHF, BiPaP, CPAP , nebuliser , and or IPPV)
Exclusion criteria
No requirement for respiratory support